Ehinger, Erik http://orcid.org/0000-0002-1861-5631
Kopecky, Jan
Darabi, Anna
Visse, Edward
Edvardsson, Charlotte
Tomasevic, Gregor
Cederberg, David
Belting, Mattias
Bengzon, Johan
Siesjö, Peter
Funding for this research was provided by:
Lund University
Article History
Received: 19 September 2022
Accepted: 13 February 2023
First Online: 18 February 2023
Declarations
:
: This study was reviewed and approved by the Swedish Ethical Review Authority, no. 2019–03781, in accordance with the ethical standards of the Declaration of Helsinki. Written informed consent to participate in this study was provided by all patients.
: N/A
: Peter Siesjö is inventor in US patent application nr: 14/652,868; ANTISECRETORY FACTOR (AF) FOR USE IN THE TREATMENT OF GLIOBLASTOMA. The rest of the authors have no conflicts to disclose.